| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/10/2004 | US20040110947 such as methyl-3-[([2-[(3-chloro-2,2-dimethylpropanoyl)amino]phenyl]thio)methyl]benzoate; lipid/lipoprotein metabolism |
| 06/10/2004 | US20040110946 such as ethyl-2-[6-amino-4-(1,3-benzodioxol-5-yl)-3,5-dicyano-2-pyridinyl]propionate; drug screening; for treatment of cardiovascular disorders/diabetes |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110936 N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same |
| 06/10/2004 | US20040110920 Novel g protein-coupled receptor protein and dna thereof |
| 06/10/2004 | US20040110829 treating obesity, generalized anxiety disorder, post-traumatic stress disorder, late luteal phase dysphoric disorder (premenstrual syndrome), attention deficit disorder, with/without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa |
| 06/10/2004 | US20040110826 Alpha 2c-adrenoceptor antagonists comprising 1- (benzylamino)-1,2,4]triazolo[1,5-c]pyrimidine derivatives; Parkinson's disease, dyskinesias, antidepressants; hypotensive, antidiabetic agents; eating,sexual disorders |
| 06/10/2004 | US20040110824 2-Phenyl-1-[4(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 06/10/2004 | US20040110823 Bone disorders; cardiovascualr disorders; hormone replacement therapy |
| 06/10/2004 | US20040110817 Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110803 especially salts, prodrugs or active derivatives thereof; optionally coadministering a compound that interferes with fatty acid synthesis. |
| 06/10/2004 | US20040110799 Use of a PPAR-alpha agonist to treat patients suffering from weight gain associated with a PPAR-gamma agonist treatment |
| 06/10/2004 | US20040110794 Novel piperidine derivatives as modulators of chemokine receptors |
| 06/10/2004 | US20040110793 Heterocyclo inhibitors of potassium channel function |
| 06/10/2004 | US20040110768 (S)-3-(1H-indol-3-yl)-N-(1-methoxymethyl-cyclohexylmethyl)-2-methyl-2-[4-(4-nitro-phenyl)-oxazol-2-ylamino]-propionamide for example; cancer, psychological disorders, sexual disorders, eating disorders, inflammatory bowel disease, sleep disorders |
| 06/10/2004 | US20040110763 Pyrazolopyridine compound and pharmaceutical use thereof |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110693 Agent for treating diabetes mellitus |
| 06/10/2004 | US20040110692 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110287 Culturing pancreatic tissue for use in replenishment of functional glucose-sensing, insulin-secreting pancreatic beta cells; pancreatic injury and diabetes treatments |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040110164 L-methionine $g(g)-lyase with modified function |
| 06/10/2004 | US20040109891 Antidiabetic agents |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | CA2506949A1 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia |
| 06/10/2004 | CA2485562A1 Appetite suppressant toothpaste |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426374A1 Naphthyridine derivative |
| 06/09/2004 | EP1426370A1 Propanolamine derivative having 1,4 benzodioxane ring |
| 06/09/2004 | EP1426366A1 Thiazolidine derivative and medicinal use thereof |
| 06/09/2004 | EP1426048A2 Treating hypertriglyceridemia with RXR agonists in combination with a PPARgamma agonist |
| 06/09/2004 | EP1426046A1 Novel use of tricyclic compound |
| 06/09/2004 | EP1425974A1 A process for tea flower |
| 06/09/2004 | EP1425388A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 06/09/2004 | EP1425284A2 Furo- and thienopyrimidine derivatives as angiogenesis inhibitors |
| 06/09/2004 | EP1425280A2 Hetero-bicyclic crf antagonists |
| 06/09/2004 | EP1425279A2 Method for the preparation of crystalline tetrahydrobenzothiepines |
| 06/09/2004 | EP1425267A2 C2-substituted indane-1-ones and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425266A1 C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments |
| 06/09/2004 | EP1425265A1 Derivatives of c2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments |
| 06/09/2004 | EP1425264A1 C2-disubstituted indane-1-ol systems, method for their production and their use as medicaments |
| 06/09/2004 | EP1425256A1 Method for preparing unsaturated fatty hydroxy-acids and esters thereof, their use in pharmaceutical and/or cosmetic compositions |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425034A1 Method for treating coumarin-induced hemorrhage |
| 06/09/2004 | EP1425030A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 06/09/2004 | EP1425025A1 Ayurvedic composition for diabetes |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425019A1 Pharmaceutical composition |
| 06/09/2004 | EP1425018A1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof |
| 06/09/2004 | EP1425014A1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 06/09/2004 | EP1425010A1 Substituted indoles and their use as integrin antagonists |
| 06/09/2004 | EP1425007A1 Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1425003A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 06/09/2004 | EP1425000A1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1424999A1 Use of c2-substituted indane-1-one systems for producing medicaments for the prophylaxis or treatment of obesity |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424985A1 Use of derivatives of c2-substituted indan-1-ol systems for producing medicaments for the prophylaxis or the treatment of obesity |
| 06/09/2004 | EP1424907A1 Oil composition |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1240137B1 Method for making 24(s)-hydroxyvitamin d 2 |
| 06/09/2004 | EP1235797B1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode |
| 06/09/2004 | EP1180102B1 Mutual prodrugs of amlodipine and atorvastatin |
| 06/09/2004 | EP1173436B1 Thiazolidinedione derivative and its use as antidiabetic |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | EP1007043B1 Method for treatment of cns-involved lysosomal storage diseases |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | DE10142667B4 C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel C2-substituted indan-1-ols and their derivatives, and their use as medicaments |
| 06/09/2004 | DE10142661B4 Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel Multiple-substituted indan-1-ol-systems and their use as medicaments |
| 06/09/2004 | CN1503801A Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino [2,3-f] quinoxaline |
| 06/09/2004 | CN1503800A antidepressant indoletetrahydropyridine derivatives of 2,3-dihydro-7h-[1,4] dioxino [2,3-3] indole |
| 06/09/2004 | CN1503799A Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza cyclopenta [A] naphthalene |
| 06/09/2004 | CN1503798A Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused- [1,4]-derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 06/09/2004 | CN1503797A Pyridopyrimidine or naphthyridine derivative |
| 06/09/2004 | CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 06/09/2004 | CN1503774A Carboxylic acid derivative and thereof |
| 06/09/2004 | CN1503676A Method for treating gout and reducing serum uric a cid |
| 06/09/2004 | CN1503673A antiinflammation agents |
| 06/09/2004 | CN1503664A Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 06/09/2004 | CN1503634A Method for preparing vitamin B enriched products from grasses |
| 06/09/2004 | CN1503632A Nutritional composition for immune condition |
| 06/09/2004 | CN1502695A Mouse cholesterol ester synthetase-2 gene promotor |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502338A Process for preparing red active nano elementary selengelatin microcapsule |
| 06/09/2004 | CN1502322A Pharmaceutical dosage form and method of making |
| 06/09/2004 | CN1152878C Thiazolidinedione derivative and use as antidiabetic |
| 06/09/2004 | CN1152877C Piperazine derivatives |
| 06/09/2004 | CN1152863C Substituted pyridines as selective coclooxygenase-2-inhibitors and composition thereof |
| 06/09/2004 | CN1152709C Phospholipid capsule compsotion with effective blood-lipid regulation function and use thereof |
| 06/09/2004 | CN1152692C Silkworm excrement extracting process, extract and its use |
| 06/09/2004 | CN1152691C Use of chemically-stabilized chloride solution for inhibiting antigen-specific immune response |
| 06/09/2004 | CN1152685C Usage of endothelin receptor agonist in preparation of medicine for treating obesity |